September 04, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Pfizer To Revert To ‘Business As Normal’ After Pricing Increase Pause, CEO Says On Earnings CallThe pharmaceutical giant signaled that prescription drug price increases could return in 2019 after postponing planned hikes in July. The news was made during Pfizer's third-quarter earnings call, in which the drugmaker also … Read More
In Search Of Insurance Savings, Consumers Can Get Unwittingly Wedged Into Narrow-Network Plans… Read More
Viewpoints: GOP Is Still Pushing To Take Away Comprehensive Health Coverage; Yes, The Administration Really Is Working To Throw Out Protections For Preexisting ConditionsEditorial pages focus on these health care topics and others. from Kaiser Health News https://ift.tt/2PzwnaK … Read More
Perspectives: Trump’s Pricing Proposal Raises Questions About How U.S. Pays For DrugsRead recent commentaries about drug-cost issues. from Kaiser Health News https://ift.tt/2RnYBCv … Read More
What Will It Mean For Pharma If Democrats Take Control Of The House?News outlets report on stories related to pharmaceutical pricing. from Kaiser Health News https://ift.tt/2RnYzdR … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment